Sponsor of the Day:
Jerkmate
https://www.medtechdive.com/news/acurable-launch-sleep-apnea-diagnosis/651232/
Acurable prepares to challenge ResMed for sleep apnea diagnosis market | MedTech Dive
The company’s device records the sounds of the patient’s respiratory and cardiac functions and monitors blood oxygen levels to assess suspected obstructive...
sleep apnea diagnosismarket medtech diveprepareschallengeresmed
https://www.medtechdive.com/news/nuvasive-buys-simplify-medical-150m/595778/
NuVasive buys Simplify Medical in play for $2.6B cervical spine market | MedTech Dive
The $150 million acquisition will add to the pandemic-related challenges for NuVasive in 2021, with investments to train surgeons and run clinical trials...
market medtech dive2 6bcervical spinebuyssimplify
https://www.medtechdive.com/news/hologic-fda-approval-transplant-testing-abbott-roche/623628/
Hologic gets FDA approval to challenge Abbott, Roche in transplant testing market | MedTech Dive
The company plans to work toward approvals of transplant assays for other pathogens including the BK virus and Epstein-Barr virus to provide quantitative...
gets fda approvalmarket medtech divehologicchallengeabbott
https://www.medtechdive.com/news/dexcom-cgm-adoption-booms-as-it-looks-to-aggressively-pursue-type-2-marke/559966/
Dexcom CGM adoption booms as it looks to 'aggressively' pursue Type 2 market | MedTech Dive
Coming off another beat-and-raise quarter, the company remains focused on adding users via the pharmacy benefit channel, Medicare population and international...
market medtech divedexcom cgmtype 2adoptionbooms
https://www.medtechdive.com/news/polares-raises-40m-to-target-competitive-mitral-regurgitation-market/580604/
Polares raises $40M to target competitive mitral regurgitation market | MedTech Dive
The medtech plans to finish pilot clinical studies of a transcatheter mitral valve hemi-replacement device, seeking to treat a slice of a population that's...
market medtech diveraises 40mmitral regurgitationpolarestarget